Key Metrics of BioNexus Gene Lab Corp
Revenue$9.8M▼ 10.6% YoYFY 2023
Operating income−$2.6M▼ 790.7% YoY
Net profit−$2.6M▼ 638.6% YoY
Shareholders' equity$9.7M
Market cap$2.9MBGLC · $0.98
Competitors10identified
About BioNexus Gene Lab Corp
Sectors
Company details
- Listed
- Nasdaq: BGLC
Operational Areas of BioNexus Gene Lab Corp
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameBioNexus Gene Lab Corp
TickerBGLC
ExchangeNasdaq
CountryMalaysia
SEC CIK0001737523
Listed since—
IndustryMedical Specialities
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Website—
US market & SEC filings
BGLC · Nasdaq · SEC CIK 0001737523
Last price · 31 Oct 2026
$0.98
−7.79%
Market cap$2.9M
P/E—On FY 2023 diluted EPS
Volume4,147
SectorHealth CareMedical Specialities
Country · IPOMalaysia
BGLC share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of BioNexus Gene Lab Corp
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | hcahealthcare.com | 2011 | United States |
Similar companies
H
Healthcare Realty Trust IncorporatedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
P
PACS Group Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
O
Oscar Health Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
B
BrightSpring Health Services Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
A
American Healthcare REIT Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
O
Omega Healthcare Investors Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
K
Koninklijke Philips N.V. NY Registry SharesPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
L
Labcorp Holdings Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.